DENTOMYCIN Periodontal gel Ref.[49989] Active ingredients: Minocycline

Source: Health Products Regulatory Authority (IE)  Revision Year: 2018  Publisher: Henry Schein UK Holdings Limited, Medcare House, Centurion Close Gillingham Business Park, Gillingham Kent, ME8 0SB, United Kingdom

Product name and form

DENTOMYCIN 2% w/w Periodontal Gel.

Pharmaceutical Form

Periodontal Gel.

A Light yellow-coloured gel.

Qualitative and quantitative composition

Minocycline hydrochloride dihydrate equivalent to minocycline 2% w/w.

For a full list of excipients, see section 6.1.

Active Ingredient Description
Minocycline

Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines.

List of Excipients

Hyetellose
Magnesium chloride hexahydrate (E511)
Ammonio methacrylate Copolymer (Type B) Ph. Eur.
Triacetin (E1518)
Glycerol (E422)

Pack sizes and marketing

0.5g of gel contained in an applicator consisting of a polypropylene syring barrel, polypropylene plunger rod and elastomer cap and gasket (plunger stopper) encased in a laminated aluminium pouch.

Each carton contains 5 applicators.

Marketing authorization holder

Henry Schein UK Holdings Limited, Medcare House, Centurion Close Gillingham Business Park, Gillingham Kent, ME8 0SB, United Kingdom

Marketing authorization dates and numbers

PA1321/001/001

Date of first authorisation: 10 December 1998
Date of last renewal: 10 December 2008

Drugs

Drug Countries
DENTOMYCIN Ireland, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.